Are pharma company efforts to disclose their pricing activities having an impact on public or political perception of their practices in the US? Noting dramatic yet, it seems, but the flow of reports does invite some interesting comparisons between the firms themselves.
Eli Lilly & Co. is the latest major pharma company to issue a pricing transparency report revealing its average...